Skip to main content
Top
Published in: Endocrine 3/2018

01-09-2018 | Original Article

The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels

Authors: Xiaopeng Guo, Yumo Zhao, Man Wang, Lu Gao, Zihao Wang, Zhuhua Zhang, Bing Xing

Published in: Endocrine | Issue 3/2018

Login to get access

Abstract

Purpose

To evaluate the incidence of obstructive sleep apnea-hypopnea syndrome (OSAHS), explore the structural changes in pharyngeal soft tissue underlying OSAHS development and analyze the correlation between hormone levels and pharyngeal soft tissue changes in patients with untreated acromegaly.

Methods

Twenty-five patients with untreated acromegaly were prospectively enrolled. Pituitary hormones were tested, sellar magnetic resonance imaging was confirmed, overnight polysomnography was conducted, and upper airway computed tomography was performed on these patients.

Results

Patients with untreated acromegaly had a high incidence of OSAHS (52.0%, 13/25). The average age of the patients with OSAHS was 12 years older than that of patients without OSAHS (47.0 ± 8.5 years vs. 35.1 ± 9.5 years, p = 0.003). The posterior pharyngeal soft tissues were thicker in four different planes, including the planes of the soft palate, uvula, tongue and epiglottis (p = 0.003, 0.008, 0.027, and 0.003, respectively), and the soft palate (p = 0.024) was more hypertrophic in patients with acromegaly presenting with OSAHS than patients without OSAHS. The posterior pharyngeal wall thickness (cm) positively correlated with the serum insulin-like growth factor 1 (IGF-1) level (ng/ml) in the planes of the soft palate (slope = 0.001, p = 0.006) and epiglottis (slope = 0.002, p = 0.039).

Conclusions

OSAHS is a common complication in patients with untreated acromegaly, and advanced age is a risk factor. Posterior pharyngeal soft tissue thickening and soft palate hypertrophy are structural changes underlying OSAHS development in patients with acromegaly. Higher IGF-1 levels predict an increase in the posterior pharyngeal soft tissue thickness in patients with acromegaly.
Literature
4.
go back to reference L.M. Fatti, M. Scacchi, A.I. Pincelli, E. Lavezzi, F. Cavagnini, Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4, 259–262 (2001)CrossRefPubMed L.M. Fatti, M. Scacchi, A.I. Pincelli, E. Lavezzi, F. Cavagnini, Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4, 259–262 (2001)CrossRefPubMed
5.
go back to reference R.R. Grunstein, K.Y. Ho, C.E. Sullivan, Sleep apnea in acromegaly. Ann. Intern. Med. 115, 527–532 (1991)CrossRefPubMed R.R. Grunstein, K.Y. Ho, C.E. Sullivan, Sleep apnea in acromegaly. Ann. Intern. Med. 115, 527–532 (1991)CrossRefPubMed
6.
go back to reference W. Hochban, K. Ehlenz, R. Conradt, U. Brandenburg, Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur. Respir. J. 14, 196–202 (1999)CrossRefPubMed W. Hochban, K. Ehlenz, R. Conradt, U. Brandenburg, Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur. Respir. J. 14, 196–202 (1999)CrossRefPubMed
8.
go back to reference S. Dostalova, K. Sonka, Z. Smahel et al. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur. J. Endocrinol. 144, 491–497 (2001)CrossRefPubMed S. Dostalova, K. Sonka, Z. Smahel et al. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur. J. Endocrinol. 144, 491–497 (2001)CrossRefPubMed
17.
go back to reference M.S. Ip, K.C. Tan, W.C. Peh, K.S. Lam, Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin. Endocrinol. 55, 477–483 (2001)CrossRef M.S. Ip, K.C. Tan, W.C. Peh, K.S. Lam, Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin. Endocrinol. 55, 477–483 (2001)CrossRef
20.
go back to reference F. Rosenow, S. Reuter, U. Deuss et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin. Endocrinol. 45, 563–569 (1996)CrossRef F. Rosenow, S. Reuter, U. Deuss et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin. Endocrinol. 45, 563–569 (1996)CrossRef
22.
go back to reference C.F. Mello Jr, H.A. Guimaraes Filho, C.A. Gomes, C.C. Paiva, Radiological findings in patients with obstructive sleep apnea. J. Bras. Pneumol. 39, 98–101 (2013)CrossRef C.F. Mello Jr, H.A. Guimaraes Filho, C.A. Gomes, C.C. Paiva, Radiological findings in patients with obstructive sleep apnea. J. Bras. Pneumol. 39, 98–101 (2013)CrossRef
23.
go back to reference L. Pelttari, O. Polo, E. Rauhala et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin. Endocrinol. 43, 175–182 (1995)CrossRef L. Pelttari, O. Polo, E. Rauhala et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin. Endocrinol. 43, 175–182 (1995)CrossRef
25.
go back to reference B.L. Herrmann, T.E. Wessendorf, W. Ajaj et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur. J. Endocrinol. 151, 309–315 (2004)CrossRefPubMed B.L. Herrmann, T.E. Wessendorf, W. Ajaj et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur. J. Endocrinol. 151, 309–315 (2004)CrossRefPubMed
26.
go back to reference C. Berg, T.E. Wessendorf, F. Mortsch et al. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur. J. Endocrinol. 161, 829–835 (2009)CrossRefPubMed C. Berg, T.E. Wessendorf, F. Mortsch et al. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur. J. Endocrinol. 161, 829–835 (2009)CrossRefPubMed
Metadata
Title
The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels
Authors
Xiaopeng Guo
Yumo Zhao
Man Wang
Lu Gao
Zihao Wang
Zhuhua Zhang
Bing Xing
Publication date
01-09-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1631-3

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue